PRINCETON, New Jersey and UXBRIDGE, England, February 7 /PRNewswire/ -- Bristol-Myers Squibb Company (NYSE: BMY) today announced results from the CASTLE study, in which 300 mg of once-daily REYATAZ(R) (atazanavir sulfate) taken with 100 mg of ritonavir (REYATAZ/r) showed similar antiviral efficacy to twice-daily lopinavir 400 mg and ritonavir 100 mg (lopinavir/r) in previously untreated adult HIV-1 infected patients at 48 weeks, as part of HIV combination therapy. In this study, 78 percent of the 440 patients in the REYATAZ/r arm met the primary endpoint of achieving undetectable viral load (defined as HIV-1 RNA less than 50 copies/mL) at 48 weeks, compared with 76 percent of the 443 patients in the lopinavir/r arm.

JENA, Germany, February 7 /PRNewswire/ -- Occlutech GmbH, the leading European manufacturer of coronary occlusion devices today announced that it has obtained approval for its IP position in relation to patents held by AGA Medical Inc. from AIPPI, the European International Association for the Protection of Intellectual Property.

AIPPI is the world's leading non-government organization for research into and protection of intellectual property, and is a respected source for opinions and arbitration on IP matters such as patent interpretation and the use of IP in unfair competition.

NEW YORK, February 7 /PRNewswire/ --

Hudson Highland Group, Inc. (Nasdaq: HHGP), one of the world's leading providers of permanent recruitment, contract professionals and talent management solutions, today announced financial results for the fourth quarter and full-year ended December 31, 2007.

MONTREAL, Canada, February 6 /PRNewswire/ --

- Shipment of Prion Capture Resin to MacoPharma in Q1 2008;

- MacoPharma Increased its Forecast for P-Capt(R) Filters Sale in 2008;

- Use of Affinity Prion Adsorbent for Plasma-Derived Products to Generate in Excess of CAD$25 M Over the Next 5 Years - CAD$4 M in 2008;

- 10th Product Approved by the FDA and or the EMEA, Contributing to Revenue Growth.

ProMetic Life Sciences Inc. (TSX:PLI) ("ProMetic") today provided an update on its business activities.

CHICAGO and PARIS, February 6 /PRNewswire/ --

- Leading North American Traffic Provider to Launch Multiple European Products in 2008

NAVTEQ (NYSE: NVT), a leading global provider of digital map data for vehicle navigation and location based solutions, today announced the expansion of NAVTEQ Traffic to Europe. The company has announced plans to introduce both its real-time NAVTEQ Traffic product and NAVTEQ Traffic Patterns, a product featuring historic traffic data that further optimizes routing in navigation systems and on-line mapping, in Europe in 2008.

LAS VEGAS, Nevada, February 6 /PRNewswire/ -- Diagnostic Imaging International Corp. (OTC: DIIG) was pleased to announce today that the Company stock symbol has been cleared for quotation on the OTC Bulletin Board.

The trading symbol is DIIG.

Additionally the Company announced today that the corporate website is now live at http://www.diig.biz

The Company plans to work diligently to build on its business plan as quickly as possible.

About the Company